2019 Product Theaters

*These are non-CME accredited sessions.

ADC is happy to announce six product theaters beginning on Friday morning at 8:00 am.  Plan to attend as Regeneron and Sanofi Genzyme, Ortho-Dermatologics, Celgene, Janssen, AbbVie, and Lilly present on their latest products and services (these are non-CME accredited sessions).

FRIDAY  |  MAY 3, 2019

8:00 am – 8:45 am
DUPIXENT® (dupilumab): Now Approved for an Expanded Indication
Benjamin Lockshin, MD, FAAD, Georgetown University Hospital
Presented by: Regeneron and Sanofi Genzyme

10:45 am – 11:30 am
SILIQ: The First and Only IL-17 Receptor Blocker for Psoriasis
Michael Siegel, MD, Siegel Dermatology
Presented by Ortho-Dermatologics

11:45 am – 12:45 pm
Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
Leon Kircik, MD, DermResearch PLLC
Presented by: Celgene

7:00 pm - 7:45 pm
TREMFYA®: A First-line Biologic With Clinical Data vs Adalimumab and Secukinumab
Steve Feldman, MD, PhD, The Dermatologist, NC
Presented by: Janssen

SATURDAY  |  MAY 4, 2019

7:00 am – 7:45 am
Uncovering Clearance - Introducing SKYRIZI for Adults with Moderate to Severe Plaque Psoriasis
Jeremy Moss, MD
Presented by: AbbVie

SUNDAY  |  MAY 5, 2019

7:00 am – 7:45 am
A View of Ongoing Experience with Taltz Efficacy and Safety
Alice Gottlieb, MD, New York Medical College
Presented By: Lilly, USA